CompoAtlas

FEMICONF

Food supplement declared in France, declaration No 2016-9-150, decision dated 7 September 2016

FEMICONF (S&P) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 2 rules of use apply to its ingredients (limits and warnings).

Brand
S&P
Food business operator placing the product on the market
NHM sprl
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
1 gélule par jour
Directions for use
Prendre 1 gélule par jour
Intended populations
Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Antécédent de cancer du sein
Objectives stated by the manufacturer (these are not authorised claims)
Cycles féminins

Declaration 275918, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Alchemilla vulgaris L.Parties aériennesExtrait sec aqueux150 mg
Achillea millefolium L.Parties aériennesExtrait sec hydroalcoolique70 mg
Urtica dioica L.RacineExtrait sec hydroalcoolique50 mg
Vitis vinifera L.FeuilleExtrait sec hydroalcoolique50 mg
Vitex agnus-castus L.FruitExtrait sec aqueux22 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acétate de D-alpha-tocophéryleVitamine E300 mg30 mg

Additives

E464, E460, E551

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Demander l’avis de votre médecin et/ou pharmacien. Produit déconseillé aux femmes allaitantes ainsi qu’aux femmes ayant des antécédents personnels ou familiaux de cancer du sein.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : S&P

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line